February 13, 2018 / 6:25 AM / 12 days ago

REFILE-TABLE-Sawai Pharmaceutical- 9-MTH group results

 (Adds company forecast. Accounting policy for forecast is IFRS)
Feb 13 (Reuters)- 
Sawai Pharmaceutical Co Ltd 
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)

                   9 months ended      9 months ended       Year to
                  Dec 31, 2017        Dec 31, 2016     Mar 31, 2018
                     LATEST             YEAR-AGO          LATEST
                     RESULTS             RESULTS         FORECAST
  Sales              116.54              101.38           168.80
                   (+15.0 pct)         (+9.7 pct)
  Operating           19.10               17.90            23.70
                   (+6.7 pct)          (-7.4 pct)
  Recurring           19.67               17.87            23.30
                   (+10.1 pct)         (-6.5 pct)
  Net                 14.04               13.69            12.80
                   (+2.6 pct)          (-2.2 pct)
  EPS              377.01 yen          371.35 yen       343.59 yen
  EPS Diluted      376.76 yen          371.13 yen
  Ann Div                              130.00 yen       130.00 yen
  -Q2 div           65.00 yen           65.00 yen
  -Q4 div                               65.00 yen        65.00 yen

NOTE - Sawai Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T  
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below